BDNF and small cell lung carcinoma: In addition, upregulation of neurotrophin signalling foreshadows that poly(adenosine diphosphate‐ribose) polymerase (PARP) inhibitors can be effective therapeutic agents for SCLC‐P as previously proposed,13 as prolonged PARP activation was found to contribute to neurotrophin‐induced neuronal death.71